KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Bortezomib, a therapeutic agent for multiple myeloma (MM) and mantle cell lymphoma, suppresses proteosomal degradation leading to substantial changes in cellular transcriptional programs and ultimately resulting in apoptosis. Transcriptional regulators required for bortezomib-induced apoptosis in MM...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mannava, Sudha, Zhuang, DaZhong, Nair, Jayakumar R., Bansal, Rajat, Wawrzyniak, Joseph A., Zucker, Shoshanna N., Fink, Emily E., Moparthy, Kalyana C., Hu, Qiang, Liu, Song, Boise, Lawrence H., Lee, Kelvin P., Nikiforov, Mikhail A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286209/
https://ncbi.nlm.nih.gov/pubmed/22144178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-346676
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars